Using a cytokine filter during pediatric heart surgery
Part of Blood & lymphatic, Heart & circulation, Immune system & allergy clinical trials.
This study tests whether adding a special filter (called a cytokine adsorber) to the heart-lung machine during your child's open-heart surgery can reduce harmful inflammation and help them recover better. The filter is used alongside the standard heart-lung machine during the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 10 years old or younger and weigh at least 5 kg (about 11 pounds).
- Your child must be scheduled for open-heart surgery that uses a heart-lung machine for at least 2 hours.
- Your child cannot have a weakened immune system (from long-term steroids, chemotherapy, or other immune-suppressing medicines).
- Your child cannot be allergic to heparin or have a related blood condition.
- Your child cannot have a very low blood platelet count (below 20) before surgery.
- You (parent or legal guardian) must be able to read and understand French or English, and give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether removing certain inflammation signals (cytokines) can help people with severe heart infection (infective endocarditis) who are having heart surgery soon. It may help reduce harmful inflammation around the time of surgery, but it also has several medication and health-condition requirements.
This trial tests a special blood filter used during children's heart surgery to reduce inflammation. It may help children recover faster after long operations.
This trial tests a device that filters the blood during urgent heart surgery. It may help patients who take blood thinners by reducing bleeding risks during surgery.
This study compares two ways of removing extra fluid from the body during heart surgery with a heart-lung machine in children under 5. The goal is to find which method is safer and works better.
This study looks at how managing blood products during heart surgery with a heart-lung machine affects the risk of red blood cell breakdown in children. The goal is to find safer ways to handle blood during these procedures.
This trial studies patterns in immune cells (neutrophils) in very young children who undergo heart surgery using a heart-lung machine. The goal is to better understand and potentially reduce lung injury after surgery.
Hear when a new Cardiac Surgery Recovery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.